Tracon Pharmaceuticals Inc

TRACON Pharmaceuticals, Inc. is a clinical state biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related muscular degeneration, and fibrotic diseases. The Company uses endoglin biology to develop antibodies that bind to the endoglin receptor. TRACON operates in the United States.